If you need more lookups,
subscriptions start at $34 USD/month.
Keith Phillips Location
United Kingdom
Keith Phillips Work
2023 -now Vice President, Head of Novel Therapeutic Modalities @
2020 -2023 Associate Vice President, Neuroscience Next Generation Therapeutics @ Eli Lilly and Company
2019 -2020 Research Advisor @ Eli Lilly and Company
2017 -2020 Principal Research Scientist @ Eli Lilly and Company
2014 -2017 Senior Research Scientist @ Eli Lilly and Company
2011 -2014 Research Scientist @ Eli Lilly and Company
2008 -2011 Postdoctoral Research Fellow @
2002 -2003 Student Placement @ Eli Lilly
Keith Phillips Education
Cardiff University / Prifysgol Caerdydd
PhD (Neuroscience)
2003-2007
University of Southampton
BSc (Pharmacology)
1999-2004
Keith Phillips Skills
Biomarkers
In Vivo
Electrophysiology
Ion Channels
Neuropharmacology
Target Identification
Animal Models
Neuroscience
Translational Medicine
Drug Discovery
Pharmacology
In Vitro
Public Speaking
Project Management
Teaching
PowerPoint
Customer Service
Molecular Biology
Keith Phillips Summary
Keith Phillips, based in United Kingdom, is currently a Vice President, Head of Novel Therapeutic Modalities at Grünenthal Group. Keith Phillips brings experience from previous roles at Eli Lilly and Company. Keith Phillips holds a 2003 - 2007 PhD in Neuroscience @ Cardiff University / Prifysgol Caerdydd. With a robust skill set that includes Biomarkers, In Vivo, Electrophysiology, Ion Channels, Neuropharmacology and more. Keith Phillips has 4 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Keith Phillips?
Find contact details for 700 million professionals.